Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bearish
Hugel Inc
Watchlist
Hugel Placement: A 5.2% Block Deal Sale
Equity Capital Markets
412 Views
29 Jun 2020 10:11
After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »
Loading
Trending Collections
More »
South Korea
India
Event-Driven
Japan
Equity Bottom-Up
Index Rebalance
Asia ECM
Sell / Short Ideas
Asia (APAC)
Europe Event-Driven
Trending Insights
More »
Hygon/Sugon Merger: BIG Index Flows on Completion
Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
Holcim Spin-off (Amrize) Deep Dive
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Merger Arb Mondays (23 June) - ENN Energy, Dickson, HKBN, Mayne, Insignia, Santos, Smartpay
Top Unpaywalled Insights
More »
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
[IO Technicals 2025/25] Bearish Momentum Strengthens
VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Medy Tox Inc (086900 KS): Legal Battle Continues; Muted Recovery in Export Revenue
06 Jul 2022
Korean Botox Players in Another Round of Patent Fights: Medytox (086900 KS) Sues Hugel (145020 KS)
19 Apr 2022
The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?
14 Aug 2021
Hugel Placement: A 5.2% Block Deal Sale
29 Jun 2020
Daewoong: Entering "Botox World"
27 Mar 2019
Hugel: Botulinum Injects Sales from Exports
10 Aug 2017
Spin-Offs Can Deliver Real Alpha in Korea
14 Aug 2016
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x